MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03264cam a22003254a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20231012085326.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
080310s2009 paua 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780781741187 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0781741181 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
BUL |
| Transcribing agency |
BUL |
| Modifying agency |
BUL |
| Language of cataloging |
eng |
| Description conventions |
rda |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 18.2 F499pa 2006 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Howland, Richard D. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Pharmacology / |
| Statement of responsibility, etc. |
Richard D. Howland, Mary J. Mycek ; editors, Richard A. Harvey, Pamela C. Champe |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
3rd edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Philadelphia : |
| Name of publisher, distributor, etc. |
Lippincott Williams & Wilkins, |
| Date of publication, distribution, etc. |
c2006. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
552 p. : |
| Other physical details |
ill. (some col.) ; |
| Dimensions |
28 cm. |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
Lippincott's illustrated reviews |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Contents<br/><br/>Unit I: INTRODUCTION TO PHARMACOLOGY <br/>Chapter 1: Pharmacokinetics <br/>Chapter 2: Drug-Receptor Interactions and Pharmacodynamics<br/><br/>Unit II: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM <br/>Chapter 3: The Autonomic Nervous System <br/>Chapter 4: Cholinergic Agonists <br/>Chapter 5: Cholinergic Antagonists <br/>Chapter 6: Adrenergic Agonists <br/>Chapter 7: Adrenergic Antagonists<br/><br/>Unit III: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM <br/>Chapter 8: Treatment of Neurodegenerative Diseases <br/>Chapter 9: Anxiolytic and Hypnotic Drugs <br/>Chapter 10: Central Nervous System Stimulants <br/>Chapter 11: Anesthetics <br/>Chapter 12: Antidepressants <br/>Chapter 13: Neuroleptic drugs<br/>Chapter 14: Opioid analgesics and antagonists <br/>Chapter 15: Drugs used to Epilepsy<br/><br/>Unit IV: DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM <br/>Chapter 16: The treatment of Heart Failure <br/>Chapter 17: Antiarrhythmic drugs<br/>Chapter 18: Antianginal Drugs <br/>Chapter 19: Antihypertensive drugs<br/>Chapter 20: Drugs affecting the blood<br/>Chapter 21: Antihyperlipidemic drugs<br/>Chapter 22: Diuretic drugs<br/><br/>Unit V: DRUGS AFFECTING THE ENDOCRINE SYSTEM <br/>Chapter 23: Hormones of the Pituitary and Thyroid <br/>Chapter 24: Insulin and Oral Hypoglycemic Drugs <br/>Chapter 25: Estrogens and Androgens <br/>Chapter 26: Adrenocorticosteroids<br/><br/>Unit VI: DRUGS AFFECTING OTHER SYSTEMS <br/>Chapter 27: Drugs affecting the Respiratory System <br/>Chapter 28: Gastrointestinal and Antiemetic Drugs <br/>Chapter 29: Erectile dysfunction, osteoporosis and obesity<br/><br/>Unit VII: CHEMOTHERAPEUTIC DRUGS <br/>Chapter 30: Principles of Antimicrobial Therapy <br/>Chapter 31: Inhibitors of Cell Wall synthesis<br/>Chapter 32: Protein Synthesis Inhibitors <br/>Chapter 33: Folate antagonists, quinolones and urinary tract antiseptics<br/>Chapter 34: Antimycobacterial Drugs <br/>Chapter 35: Antifungal Drugs <br/>Chapter 36: Antiprotozoal Drugs <br/>Chapter 37: Anthelmintic Drugs <br/>Chapter 38: Antiviral Drugs <br/>Chapter 39: Anticancer Drugs <br/>Chapter 40: Immunosuppressants<br/><br/>Unit VI: ANTI-INFLAMMATORY DRUGS AND AUTOCOIDS <br/>Chapter 41: Anti-inflammatory Drugs <br/>Chapter 42: Autacoids & Autacoid Antagonists<br/> |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology |
| Form subdivision |
Outlines, syllabi, etc. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology |
| Form subdivision |
Examinations, questions, etc. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology |
| Form subdivision |
Examination Questions. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology |
| Form subdivision |
Outlines. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Mycek, Mary J. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Harvey, Richard A. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Champe, Pamela C. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Book Open Access |
| Edition |
3rd edition |
| Classification part |
QV 18.2 F499pa 2006 |
| Item part |
1 |
| Call number prefix |
QV 18.2 |
| Call number suffix |
F499pa 2006 |
